IMA
ImageneBio, Inc.
4.70$
+1.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +15.1% | -4.8% | -7.9% | -97.7% | +5,244.6% | +2.2% | +5.6% | +439.7% | -83.3% | -88.7% | +1,575.9% | -14.9% | -2.5% | -62.3% | -40.9% | -44.4% | – | – | – | -100.0% | – | -100.0% | – | – | – | – | – | |
| – | +32.3% | -19.8% | +14.0% | +224.2% | -57.2% | +13.5% | +17.6% | -7.8% | +16.3% | +8.0% | +21.7% | -17.0% | -0.6% | -8.8% | -98.3% | +26.0% | +3,062.3% | -95.9% | +1,604.5% | -32.8% | -18.9% | -98.8% | -7,406.7% | – | -69.0% | – | – | |
| – | – | – | – | – | – | – | – | – | -239.1% | – | – | – | – | – | – | -62.5% | -2,824.6% | – | – | – | – | -105.6% | – | -113.7% | – | – | – | |
| – | +32.3% | -19.8% | +14.0% | +224.2% | -57.2% | +13.5% | +17.6% | -7.8% | +16.3% | +8.0% | +21.7% | -17.0% | -0.6% | -2.4% | -92.2% | +1,078.8% | -31.0% | +1.9% | -30.7% | -32.8% | -11.8% | -0.4% | +286.5% | -66.4% | +14.0% | +11.9% | – | |
| – | +9.9% | -28.4% | +2.6% | +47.3% | +16.8% | +53.2% | +0.6% | +4.0% | +18.0% | -2.6% | -7.1% | -9.3% | +7.1% | +0.9% | +13.4% | +37.4% | -27.7% | -11.5% | -10.0% | +59.0% | -63.7% | +60.3% | +149.9% | -96.6% | +1,553.5% | -16.4% | – | |
| – | +9.9% | -28.4% | +2.6% | +47.3% | +16.8% | +53.2% | +0.6% | +4.0% | +18.0% | -2.6% | -7.1% | -9.3% | +7.1% | +19.5% | +224.2% | +8.9% | -61.5% | +79.7% | -63.8% | +42.0% | -14.4% | +28.1% | +205.5% | -70.1% | +49.9% | -1.0% | – | |
| – | – | – | – | – | – | – | – | – | -707.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -702.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +129.6% | -83.9% | +430.0% | -47.2% | -46.4% | -593.3% | – | – | +60.0% | – | |
| – | – | – | – | – | – | – | – | – | -702.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -662.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.